Literature DB >> 17409017

Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis.

Isabelle Nefkens1, Jean-Michel Garcia, Chu Shui Ling, Nadège Lagarde, John Nicholls, Dong Jiang Tang, Malik Peiris, Philippe Buchy, Ralf Altmeyer.   

Abstract

BACKGROUND: Highly pathogenic avian influenza (HPAI) H5N1 has spread globally in birds and infected over 270 humans with an apparently high mortality rate. Serologic studies to determine the extent of asymptomatic H5N1 infection in humans and other mammals and to investigate the immunogenicity of current H5N1 vaccine candidates have been hampered by the biosafety requirements needed for H5N1 micro-neutralization tests.
OBJECTIVE: Development of a serodiagnostic tool for highly pathogenic influenza that reproduces H5N1 biology but can be used with less biohazard. STUDY
DESIGN: We have generated and evaluated H5 hemagglutinin pseudotyped lentiviral particles encoding the luciferase reporter (H5pp).
RESULTS: H5pp entry into target cells depends on alpha2-3 cell surface sialic acids and requires low pH for membrane fusion. H5pp infectivity is specifically neutralized by sera from patients and animals infected with H5N1 and correlates well with conventional microneutralization test.
CONCLUSIONS: H5pp reproduce H5N1 influenza virus entry into target cells and potentially provides a high-throughput and safe method for sero-epidemiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409017     DOI: 10.1016/j.jcv.2007.02.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  39 in total

1.  Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment.

Authors:  Feng Li; Liqiang Feng; Weiqi Pan; Zhenyuan Dong; Chufang Li; Caijun Sun; Ling Chen
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

2.  H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44.

Authors:  Joanna W Ho; Oren Hershkovitz; Malik Peiris; Alon Zilka; Ahuva Bar-Ilan; Beatrice Nal; Kid Chu; Mateusz Kudelko; Yiu Wing Kam; Hagit Achdout; Michal Mandelboim; Ralf Altmeyer; Ofer Mandelboim; Roberto Bruzzone; Angel Porgador
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

3.  Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities.

Authors:  Christoph Geisler; Donald L Jarvis
Journal:  Glycobiology       Date:  2011-08       Impact factor: 4.313

4.  Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection.

Authors:  Huailiang Ma; François Kien; Maxime Manière; Yang Zhang; Nadège Lagarde; Kong San Tse; Leo Lit Man Poon; Béatrice Nal
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice.

Authors:  Brendan M Giles; Stephanie J Bissel; Jodi K Craigo; Dilhari R Dealmeida; Clayton A Wiley; Terrence M Tumpey; Ted M Ross
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

6.  Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus.

Authors:  Philippe Buchy; Sirenda Vong; Simon Chu; Jean-Michel Garcia; Tran Tinh Hien; Vo Minh Hien; Mey Channa; Do Quang Ha; Nguyen Van Vinh Chau; Cameron Simmons; Jeremy J Farrar; Malik Peiris; Menno D de Jong
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

7.  Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret.

Authors:  Srinivas S Rao; Wing-Pui Kong; Chih-Jen Wei; Neal Van Hoeven; J Patrick Gorres; Martha Nason; Hanne Andersen; Terrence M Tumpey; Gary J Nabel
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

8.  Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.

Authors:  Luis Martínez-Sobrido; Richard Cadagan; John Steel; Christopher F Basler; Peter Palese; Thomas M Moran; Adolfo García-Sastre
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 9.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

10.  Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

Authors:  Jean-Michel Garcia; Stephanie Pepin; Nadège Lagarde; Edward S K Ma; Frederick R Vogel; Kwok H Chan; Susan S S Chiu; J S M Peiris
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.